Yongping Zhu

872 total citations
36 papers, 594 citations indexed

About

Yongping Zhu is a scholar working on Molecular Biology, Complementary and alternative medicine and Immunology. According to data from OpenAlex, Yongping Zhu has authored 36 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Complementary and alternative medicine and 5 papers in Immunology. Recurrent topics in Yongping Zhu's work include Natural Compounds in Disease Treatment (6 papers), Malaria Research and Control (4 papers) and Synthesis and Catalytic Reactions (3 papers). Yongping Zhu is often cited by papers focused on Natural Compounds in Disease Treatment (6 papers), Malaria Research and Control (4 papers) and Synthesis and Catalytic Reactions (3 papers). Yongping Zhu collaborates with scholars based in China, Singapore and United States. Yongping Zhu's co-authors include Jigang Wang, Yuqing Meng, Liwei Gu, Junzhe Zhang, Piao Luo, Yongfang Zhao, Peng Gao, Nan Ma, Xuejun C. Zhang and Huifang Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Journal of Clinical Investigation.

In The Last Decade

Yongping Zhu

34 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongping Zhu China 13 247 96 71 66 66 36 594
Yifei Dai China 16 340 1.4× 74 0.8× 40 0.6× 127 1.9× 66 1.0× 38 674
Rakesh Arya India 18 362 1.5× 62 0.6× 74 1.0× 136 2.1× 69 1.0× 36 746
Siddharth Manvati India 12 326 1.3× 98 1.0× 38 0.5× 44 0.7× 29 0.4× 15 583
Sheng Yao China 14 283 1.1× 50 0.5× 35 0.5× 36 0.5× 25 0.4× 37 641
Wenqin Liu China 11 217 0.9× 37 0.4× 54 0.8× 53 0.8× 25 0.4× 39 480
Anila Dwivedi India 16 205 0.8× 68 0.7× 45 0.6× 45 0.7× 161 2.4× 32 549
Bipul R. Acharya India 11 273 1.1× 67 0.7× 43 0.6× 49 0.7× 33 0.5× 15 593
Fanbo Jing China 13 274 1.1× 59 0.6× 25 0.4× 102 1.5× 29 0.4× 33 489
Raj Kumar Mongre South Korea 16 339 1.4× 110 1.1× 30 0.4× 82 1.2× 38 0.6× 36 737
Sook‐Kyoung Heo South Korea 16 235 1.0× 56 0.6× 39 0.5× 106 1.6× 183 2.8× 36 648

Countries citing papers authored by Yongping Zhu

Since Specialization
Citations

This map shows the geographic impact of Yongping Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongping Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongping Zhu more than expected).

Fields of papers citing papers by Yongping Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongping Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongping Zhu. The network helps show where Yongping Zhu may publish in the future.

Co-authorship network of co-authors of Yongping Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongping Zhu. A scholar is included among the top collaborators of Yongping Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongping Zhu. Yongping Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Yang, Tong, Shujie Zhang, Dandan Liu, et al.. (2025). Targeting myeloid differentiation protein 2 ameliorates rheumatoid arthritis by inhibiting inflammation and ferroptosis via MAPK and NF-κB signaling pathways. Journal of Molecular Medicine. 103(7). 821–836. 1 indexed citations
4.
Meng, Yuqing, Yanqing Liu, Yongping Zhu, et al.. (2024). Insights into the time-course cellular effects triggered by iron oxide nanoparticles by combining proteomics with the traditional pharmacology strategy. Journal of Materials Chemistry B. 12(7). 1892–1904. 1 indexed citations
5.
Zhu, Yongping, et al.. (2024). Utilizing Single-Branched Stent in Combination With Fenestration or Chimney for Endovascular Repair of Aortic Arch Lesions With Aberrant Subclavian Artery. Journal of Endovascular Therapy. 33(1). 439–452. 1 indexed citations
6.
Zhu, Yongping, Junzhe Zhang, Rui Liu, et al.. (2024). Recent Trends in anti-tumor mechanisms and molecular targets of celastrol. International Journal of Biological Sciences. 20(14). 5510–5530. 8 indexed citations
7.
Yang, Wei, Gangqiang Dong, Yan Liu, et al.. (2023). Visualization and identification of benzylisoquinoline alkaloids in various nelumbo nucifera tissues. Heliyon. 9(6). e16138–e16138. 6 indexed citations
8.
Zhang, Xing, Jing Zhou, Yongping Zhu, et al.. (2022). Quantitative chemical proteomics reveals anti-cancer targets of Celastrol in HCT116 human colon cancer cells. Phytomedicine. 101. 154096–154096. 13 indexed citations
9.
Gao, Peng, Yanqing Liu, Wei Xiao, et al.. (2022). Identification of antimalarial targets of chloroquine by a combined deconvolution strategy of ABPP and MS-CETSA. Military Medical Research. 9(1). 30–30. 19 indexed citations
10.
Luo, Piao, Fei Xia, Huan Tang, et al.. (2022). Capsaicin ameliorates inflammation in a TRPV1-independent mechanism by inhibiting PKM2-LDHA-mediated Warburg effect in sepsis. Cell chemical biology. 29(8). 1248–1259.e6. 72 indexed citations
11.
Liu, Dandan, Piao Luo, Liwei Gu, et al.. (2021). Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia–reperfusion. Journal of Neuroinflammation. 18(1). 174–174. 62 indexed citations
12.
Zhu, Yongping, et al.. (2021). miR-1287-5p upregulation inhibits the EMT and pro-inflammatory cytokines in LPS-induced human nasal epithelial cells (HNECs). Transplant Immunology. 68. 101429–101429. 12 indexed citations
13.
Gao, Peng, Xiaodong Li, Dandan Liu, et al.. (2020). <p>Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis</p>. Drug Design Development and Therapy. Volume 14. 2091–2100. 21 indexed citations
14.
Kong, Xiaohui, Xiwei Wu, Shijie Yang, et al.. (2020). Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease–associated autoimmunity. Journal of Clinical Investigation. 131(1). 24 indexed citations
15.
Liu, Yuqing, Xiaoqi Wang, Yongping Zhu, et al.. (2020). Haploidentical mixed chimerism cures autoimmunity in established type 1 diabetic mice. Journal of Clinical Investigation. 130(12). 6457–6476. 5 indexed citations
16.
Zhu, Yongping, Dong Zhang, Yuqing Meng, et al.. (2019). Eco-friendly decarboxylative cyclization in water: practical access to the anti-malarial 4-quinolones. Green Chemistry. 21(3). 478–482. 31 indexed citations
17.
Zhu, Yongping, Lingli He, Yue Liu, Yongfang Zhao, & Xuejun C. Zhang. (2019). smFRET Probing Reveals Substrate-Dependent Conformational Dynamics of E. coli Multidrug MdfA. Biophysical Journal. 116(12). 2296–2303. 6 indexed citations
18.
Lv, Xiaoting, Feng Gao, Qicai Liu, et al.. (2017). Clinical and pathological characteristics of IgG4‑related interstitial lung disease. Experimental and Therapeutic Medicine. 15(2). 1465–1473. 9 indexed citations
19.
Zhu, Yongping, et al.. (2017). Structural dynamics of Giα protein revealed by single molecule FRET. Biochemical and Biophysical Research Communications. 491(3). 603–608. 7 indexed citations
20.
Zhu, Yongping, et al.. (2012). Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp. European Archives of Oto-Rhino-Laryngology. 270(6). 1861–1865. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026